tiprankstipranks

Kaye Foster-Cheek Insider Profile

4 Followers
Kaye Foster-Cheek, Director at Agios Pharma, holds 5.48K shares in Agios Pharma (Ticker: AGIO), holds 5.80K shares in Johnson & Johnson (Ticker: JNJ), holds 0.00 shares in Onyx Pharma (Ticker: ONXX).
tipranks
Kaye Foster-Cheek

Kaye Foster-Cheek
Agios Pharma (AGIO)
Director

Ranked #46,236 out of 78,624 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-6.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
77.33%
22.67%
A breakdown of Kaye Foster-Cheek's holdings

Insider Roles

Johnson & Johnson
(JNJ)
VP HR
Agios Pharma
(AGIO)
Director
Roles that Kaye Foster-Cheek holds in companies

Most Profitable Insider Trade

Stock:
Johnson & Johnson
(JNJ)
Rating:Informative Sell
Date:Dec 11, 2009 - Dec 11, 2010
Return:0.00%
The most profitable trade made by Kaye Foster-Cheek

Kaye Foster-Cheek's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Agios Pharma
Jun 01, 2020
Director
Uninformative Buy
$244.70K
Johnson & Johnson
Jan 04, 2010
VP HR
Uninformative Buy
$834.77K
ONXX
Onyx Pharma
List of latest transactions for each holding click on a transaction to see Kaye Foster-Cheek's performance on stock

Kaye Foster-Cheek insider profile FAQ

What is the percentage of profitable transactions made by Kaye Foster-Cheek?
The percentage of profitable transactions made by Kaye Foster-Cheek is 0%.
    What is the average return per transaction made by Kaye Foster-Cheek?
    The average return per transaction made by Kaye Foster-Cheek is -6.80%.
      What stocks does Kaye Foster-Cheek hold?
      Kaye Foster-Cheek holds: AGIO, JNJ, ONXX stocks.
        What was Kaye Foster-Cheek’s latest transaction?
        Kaye Foster-Cheek latest transaction was an Uninformative Buy of ―.
          What was Kaye Foster-Cheek's most profitable transaction?
          Kaye Foster-Cheek’s most profitable transaction was an Informative Sell of JNJ stock on December 11, 2009. The return on the trade was 0.00%.
            What is Kaye Foster-Cheek's role in Agios Pharma?
            Kaye Foster-Cheek's role in Agios Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.